Stem Cell Dysfunction in Aged Skeletal Muscle
老年骨骼肌干细胞功能障碍
基本信息
- 批准号:10736449
- 负责人:
- 金额:$ 57.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Abstract
One of the greatest mysteries in ageing biology is to understand why many tissues and organs in our body,
including skeletal muscle, decline in function as we get older? Recent studies suggest that the inability of
muscle stem cells (MuSCs) to turn on the repair program after trauma is a major factor leading to the loss of
muscle mass and strength observed in the elderly. However, given that the signals driving MuSCs into the
regenerative state remains a mystery even in young adults, we are left with virtually no therapeutic options for
boosting the repair potential of aging MuSCs in the clinic. To address this unmet need, my laboratory recently
discovered a new “Super-Healing” adult stem cell activation program, driven by the transcription factor, FBJ
osteosarcoma oncogene (FOS), that speeds up adult stem cell activation and enhances muscle repair.
Intriguingly, a key downstream target gene of FOS in adult MuSCs is the NAD-consuming, cell surface
enzyme, ADP-Ribosyl-Transferase 1 (Art1), which attaches an understudied post-translational modification
(PTM), mono-ADP-Ribosylation (MARylation), to protein substrates. Excitingly, our preliminary data suggests
that the FOS/ART1-MARylation pathway is disrupted in aged MuSCs, and thus, representing one of the
earliest molecular alterations that diminish the regenerative potential of aged skeletal muscle. Thus, in this
proposal, we will test the hypothesis that the FOS/AP-1 tissue regenerative program (including the ART1
pathway) is mis-regulated in aged skeletal muscle, triggering a cascade of molecular events that dampen stem
cell activation potential and lead to the progressive deterioration of skeletal muscle with increasing age; and
most importantly, that reversal of this molecular dysfunction will correct the stem cell activation and
regenerative deficits seen in aged skeletal muscle. In Aim1, we will determine the expression patterns and
functional significance of FOS/AP-1 gene targets in adult and aged MuSCs. In Aim2, we will determine the
expression dynamics, functional requirements, and MARylated protein substrates of the newly discovered
NAD/ART1-MARylation stem cell activation pathway in adult and aged MuSCs. Collectively, this work will
highlight a new FOS/NAD/ART1-MARylation stem cell activation pathway that has been largely ignored in
aging biology until now and whose further study will open new therapeutic avenues for improving muscle
health in the elderly population.
抽象的
衰老生物学中最大的谜之一是了解为什么我们体内许多组织和器官
包括骨骼肌,随着年龄的增长,功能下降?最近的研究表明,
肌肉干细胞(MUSC)在创伤后打开修复程序是导致丧失的主要因素
在古老的情况下观察到肌肉质量和力量。但是,考虑到将MUSC驱动到的信号
即使在年轻人中,再生状态仍然是一个神秘的状态,我们几乎没有治疗选择
提高诊所中衰老的MUSC的维修潜力。为了满足这种未满足的需求,我的实验室最近
发现了一个新的“超级治疗”成人干细胞激活程序,该程序由转录因子FBJ驱动
骨肉瘤癌基因(FOS),可以加快成人干细胞的激活并增强肌肉修复。
有趣的是,成人MUSC中FOS的关键下游靶基因是NAD耗尽的细胞表面
酶,ADP-核糖基 - 转移酶1(ART1),它附着在翻译后修饰
(PTM),单ADP-核糖基化(MARYLATION),用于蛋白质底物。令人兴奋的是,我们的初步数据建议
在老年MUSC中,FOS/Art1少量途径被破坏了,因此代表其中一种
最早的分子改变减少了老化骨骼肌的再生潜力。那,这是
提案,我们将检验以下假设:FOS/AP-1组织再生程序(包括ART1
途径)在老化的骨骼肌中被错误调节,引发了一系列该死的分子事件
细胞活化潜力,并导致骨骼肌随着年龄的增长的进行性相对恶化;和
最重要的是,这种分子功能障碍的逆转将纠正干细胞激活和
在老年骨骼肌中看到的再生缺陷。在AIM1中,我们将确定表达模式和
FOS/AP-1基因靶标在成人和老年MUSC中的功能意义。在AIM2中,我们将确定
新发现的表达动力学,功能需求和玛丽化的蛋白质底物
成人和老年MUSC中的NAD/ART1降温干细胞活化途径。总的来说,这项工作将
突出显示了一种新的FOS/NAD/ART1 Marylation干细胞激活途径,该途径在很大程度上被忽略
到目前为止,衰老的生物学衰老,其进一步的研究将开放新的治疗途径,以改善肌肉
老年人的健康。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Protocol for the isolation of mouse muscle stem cells using fluorescence-activated cell sorting.
- DOI:10.1016/j.xpro.2023.102656
- 发表时间:2023-12-15
- 期刊:
- 影响因子:0
- 作者:Elizalde, Gabriel;Munoz, Alma Zuniga;Almada, Albert E.
- 通讯作者:Almada, Albert E.
共 1 条
- 1
相似国自然基金
细胞核PD-L1的ADP核糖基化修饰调控肝癌细胞免疫逃逸的分子机制
- 批准号:82372806
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
ADP-核糖基化生物功能和作用机制探究
- 批准号:22377146
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
DNA损伤应答过程中p53的多聚ADP核糖基化修饰及转录激活功能的研究
- 批准号:32301212
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PARP4通过ADP核糖基化PIPs促进结直肠癌恶性进展的机制研究
- 批准号:82203272
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
PARP4通过ADP核糖基化PIPs促进结直肠癌恶性进展的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
The Anti-Autophagy Arsenal of Legionella pneumophila
嗜肺军团菌的抗自噬阿森纳
- 批准号:1067918510679185
- 财政年份:2023
- 资助金额:$ 57.49万$ 57.49万
- 项目类别:
The non-catalytic function of PARP2 in DNA repair and cancer therapy
PARP2在DNA修复和癌症治疗中的非催化功能
- 批准号:1064193410641934
- 财政年份:2022
- 资助金额:$ 57.49万$ 57.49万
- 项目类别:
The non-catalytic function of PARP2 in DNA repair and cancer therapy
PARP2在DNA修复和癌症治疗中的非催化功能
- 批准号:1054008410540084
- 财政年份:2022
- 资助金额:$ 57.49万$ 57.49万
- 项目类别:
Chemistry and Biology of ADP-Ribosylation-Dependent Signaling
ADP 核糖基化依赖性信号传导的化学和生物学
- 批准号:1040053510400535
- 财政年份:2020
- 资助金额:$ 57.49万$ 57.49万
- 项目类别:
Determining mechanisms of innate immune modulation by ADP-ribosylation
通过 ADP-核糖基化确定先天免疫调节机制
- 批准号:1038611210386112
- 财政年份:2020
- 资助金额:$ 57.49万$ 57.49万
- 项目类别: